OPKO Health, Inc. Conversion of Stock, Amount Issued
OPKO Health, Inc. (OPK) reported Conversion of Stock, Amount Issued of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2014-05-09
- OPKO Health, Inc. conversion of stock, amount issued for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. conversion of stock, amount issued for the quarter ending 2013-12-31 was $0.00.
- OPKO Health, Inc. conversion of stock, amount issued for the quarter ending 2013-03-31 was $24.39M.
- OPKO Health, Inc. conversion of stock, amount issued for the quarter ending 2012-12-31 was $0.00.
- OPKO Health, Inc. conversion of stock, amount issued for fiscal 2013 was $24.39M.
- OPKO Health, Inc. conversion of stock, amount issued for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- OPKO Health, Inc. conversion of stock, amount issued for fiscal 2011 was $1.74M.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2014-05-09 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $24.39M 10-K · filed 2014-03-03 | ||
| 2013-09-30 | $24.39M 10-Q · filed 2013-11-12 | |||
| 2013-03-31 | $24.39M 10-Q · filed 2014-05-09 | $24.39M derived: sum of 2 quarters · filed 2014-05-09 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 10-K · filed 2014-03-03 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | |||
| 2011-12-31 | $1.74M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |